@WHO: The Technical Advisory Group met yesterday (26 October 2021) and decided that additional clarifications from the manufacturer (Bharat Biotech) are needed to conduct a final EUL risk-benefit assessment for global use of the #Covaxin vaccine. #COVID19

http://twitter.com/WHO
via IFTTT